ask="39.78"
ask_size="3000"
average_daily_volume="57963"
bid="12.16"
bid_size="200"
book_value="3.11"
change="-0.02"
change_from_200_day_moving_average="8.88"
change_from_50_day_moving_average="6.02"
change_from_52_week_high="-0.72"
change_From_52_week_low="17.63"
change_in_percent="-0.07%"
close="29.55"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.71"
ebitda="-67.56M"
eps_estimate_current_year="-2.37"
eps_estimate_next_quarter="-0.65"
eps_estimate_next_year="-2.35"
ex_dividend_date="N/A"
float_shares="11611000"
high="30.05"
high_52_weeks="30.27"
last_trade_date="3/1/2017"
last_trade_price="29.55"
last_trade_size="173"
last_trade_time="4:00pm"
low="28.05"
low_52_weeks="11.92"
market_capitalization="744.93M"
moving_average_200_day="20.67"
moving_average_50_day="23.53"
name="Ascendis Pharma A/S"
notes="N/A"
one_year_target_price="29.25"
open="29.72"
pe_ratio="N/A"
peg_ratio="-0.51"
percent_change_from_200_day_moving_average="+42.94%"
percent_change_from_50_day_moving_average="+25.58%"
percent_change_from_52_week_high="-2.38%"
percent_change_from_52_week_low="+147.90%"
previous_close="29.57"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="9.50"
price_per_sales="127.54"
revenue="5.84M"
shares_outstanding="25209000"
short_ratio="8.07"
stock_exchange="NMS"
symbol="ASND"
volume="31175"
weeks_range_52="11.92 - 30.27"
